196 related articles for article (PubMed ID: 22807084)
1. Genetics and epigenetics of hepatoblastoma.
Tomlinson GE; Kappler R
Pediatr Blood Cancer; 2012 Nov; 59(5):785-92. PubMed ID: 22807084
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic abnormalities in hepatoblastoma: report of two new cases and review of the literature suggesting imbalance of chromosomal regions on chromosomes 1, 4, and 12.
Nagata T; Nakamura M; Shichino H; Chin M; Sugito K; Ikeda T; Koshinaga T; Fukuzawa M; Inoue M; Mugishima H
Cancer Genet Cytogenet; 2005 Jan; 156(1):8-13. PubMed ID: 15588850
[TBL] [Abstract][Full Text] [Related]
3. Myc target miRs and liver cancer: small molecules to get Myc sick.
Buendia MA; Bourre L; Cairo S
Gastroenterology; 2012 Feb; 142(2):214-8. PubMed ID: 22178210
[No Abstract] [Full Text] [Related]
4. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?
Aretz S; Koch A; Uhlhaas S; Friedl W; Propping P; von Schweinitz D; Pietsch T
Pediatr Blood Cancer; 2006 Nov; 47(6):811-8. PubMed ID: 16317745
[TBL] [Abstract][Full Text] [Related]
5. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
6. Hepatoblastoma in a mosaic trisomy 18 patient.
Pereira EM; Marion R; Ramesh KH; Kim JS; Ewart M; Ricafort R
J Pediatr Hematol Oncol; 2012 May; 34(4):e145-8. PubMed ID: 22469941
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.
Buendia MA
Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.
Bläker H; Hofmann WJ; Rieker RJ; Penzel R; Graf M; Otto HF
Genes Chromosomes Cancer; 1999 Aug; 25(4):399-402. PubMed ID: 10398436
[TBL] [Abstract][Full Text] [Related]
9. Hepatoblastoma in a patient with sotos syndrome.
Kato M; Takita J; Takahashi K; Mimaki M; Chen Y; Koh K; Ida K; Oka A; Mizuguchi M; Ogawa S; Igarashi T
J Pediatr; 2009 Dec; 155(6):937-9. PubMed ID: 19914434
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring aberrations involving 1q12-q21.
Tomlinson GE; Douglass EC; Pollock BH; Finegold MJ; Schneider NR
Genes Chromosomes Cancer; 2005 Oct; 44(2):177-84. PubMed ID: 15981236
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in hepatoblastoma and hepatocellular carcinoma associated with familial adenomatous polyposis.
Cetta F; Mazzarella L; Bon G; Zuckermann M; Casorelli A; Nounga H
Med Pediatr Oncol; 2003 Nov; 41(5):496-7. PubMed ID: 14515405
[No Abstract] [Full Text] [Related]
12. Where do we stand with hepatoblastoma? A review.
Schnater JM; Köhler SE; Lamers WH; von Schweinitz D; Aronson DC
Cancer; 2003 Aug; 98(4):668-78. PubMed ID: 12910509
[TBL] [Abstract][Full Text] [Related]
13. MT1G hypermethylation: a potential prognostic marker for hepatoblastoma.
Sakamoto LH; DE Camargo B; Cajaiba M; Soares FA; Vettore AL
Pediatr Res; 2010 Apr; 67(4):387-93. PubMed ID: 20032811
[TBL] [Abstract][Full Text] [Related]
14. Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma.
Eriksson T; Frisk T; Gray SG; von Schweinitz D; Pietsch T; Larsson C; Sandstedt B; Ekström TJ
Exp Cell Res; 2001 Oct; 270(1):88-95. PubMed ID: 11597130
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic and array comparative genomic hybridization analysis of a series of hepatoblastomas.
Stejskalová E; Malis J; Snajdauf J; Pýcha K; Urbánková H; Bajciová V; Starý J; Kodet R; Jarosová M
Cancer Genet Cytogenet; 2009 Oct; 194(2):82-7. PubMed ID: 19781440
[TBL] [Abstract][Full Text] [Related]
16. AFP negative cystic liver lesion in a child should let one think of hepatoblastoma.
Goedeke J; Haeberle B; Schmid I; von Schweinitz D
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e245-7. PubMed ID: 21383638
[TBL] [Abstract][Full Text] [Related]
17. [Current status of diagnosis and treatment of hepatoblastoma].
García-Miguel P; López Santamaría M
Clin Transl Oncol; 2005 Aug; 7(7):328-34. PubMed ID: 16185597
[No Abstract] [Full Text] [Related]
18. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
Inukai T; Furuuchi K; Sugita K; Uno K; Ooi A; Sasaki F; Hamada J; Moriuchi T; Nakazawa S
Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913
[TBL] [Abstract][Full Text] [Related]
19. Current issues and controversies in the classification of pediatric hepatocellular tumors.
López-Terrada D; Zimmermann A
Pediatr Blood Cancer; 2012 Nov; 59(5):780-4. PubMed ID: 22648938
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]